Return to site

APAC Animal Health Market – Top 3 Players and their Market Growth

Factors such as rapidly increasing livestock population, increasing demand for animal-derived food products, growing awareness about animal health, and rising frequency of animal disease outbreaks.

Factors such as rapidly increasing livestock population, increasing demand for animal-derived food products, growing awareness about animal health, and rising frequency of animal disease outbreaks.

Market Size
The global APAC Animal Health market size is projected to reach USD 20.25 Billion by 2021 from USD 15.32 Billion in 2016, at a CAGR of 5.7%.

Zoetis, Inc. (U.S.), Sanofi (France), Merck and Co., Inc. (U.S.), Eli Lilly and Company (U.S.), China Animal Husbandry Industry Co., Ltd. (China), Jinyu Bio-technology Co., Ltd. (China), Qingdao Yebio Bioengineering Co., Ltd. (China), Tianjin Rringpu bio-technology Co., Ltd. (China), Kyoto Biken Laboratories, Inc. (Japan), Bio-Med Private Limited (India), and Indian Immunologicals Ltd. (India), are some key players in this market. These companies are focusing on increasing their presence in the high-growth markets through both organic as well as inorganic growth strategies such as product launches, acquisitions, and expansions.

For More Details, Download a PDF Brochure:-
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106215485

“Merck and Co., Inc. (U.S.) is another significant player in the APAC animal health market”

The company has its presence in more than 140 countries with 25 manufacturing sites located in the U.S., Mexico, Brazil, the U.K., France, Germany, Spain, the Netherlands, Germany, Italy, Austria, India, Australia, and New Zealand. The company invested USD 6,704 million, USD 7,180 Million, and USD 7,503 Million on research and development activities in 2015, 2014, and 2013, respectively, to launch new, innovative, and therapeutically effective products.

“Sanofi (France) is involved in the research, development, manufacturing, and marketing of healthcare products for humans and animals”
The company offers a wide range of animal health products through Merial, the animal health division of the company. In 2015, the company signed a business exchange agreement with Boehringer Ingelheim (Germany), one of the leading players in animal health products. Under this agreement, Sanofi will exchange its animal health business (Merial) with the consumer healthcare (CHC) business of Boehringer Ingelheim.

We can help with your specific research requirement for this market. Please share your specific interest to help us serve you better, Request Sample Pages:-
https://www.marketsandmarkets.com/requestsampleNew.asp?id=106215485

Factors such as rapidly increasing livestock population, increasing demand for animal-derived food products, growing awareness about animal health, and rising frequency of animal disease outbreaks.

Market Size
The global APAC Animal Health market size is projected to reach USD 20.25 Billion by 2021 from USD 15.32 Billion in 2016, at a CAGR of 5.7%.
Zoetis, Inc. (U.S.), Sanofi (France), Merck and Co., Inc. (U.S.), Eli Lilly and Company (U.S.), China Animal Husbandry Industry Co., Ltd. (China), Jinyu Bio-technology Co., Ltd. (China), Qingdao Yebio Bioengineering Co., Ltd. (China), Tianjin Rringpu bio-technology Co., Ltd. (China), Kyoto Biken Laboratories, Inc. (Japan), Bio-Med Private Limited (India), and Indian Immunologicals Ltd. (India), are some key players in this market. These companies are focusing on increasing their presence in the high-growth markets through both organic as well as inorganic growth strategies such as product launches, acquisitions, and expansions.
“Merck and Co., Inc. (U.S.) is another significant player in the APAC animal health market”
The company has its presence in more than 140 countries with 25 manufacturing sites located in the U.S., Mexico, Brazil, the U.K., France, Germany, Spain, the Netherlands, Germany, Italy, Austria, India, Australia, and New Zealand. The company invested USD 6,704 million, USD 7,180 Million, and USD 7,503 Million on research and development activities in 2015, 2014, and 2013, respectively, to launch new, innovative, and therapeutically effective products.
“Sanofi (France) is involved in the research, development, manufacturing, and marketing of healthcare products for humans and animals”
The company offers a wide range of animal health products through Merial, the animal health division of the company. In 2015, the company signed a business exchange agreement with Boehringer Ingelheim (Germany), one of the leading players in animal health products. Under this agreement, Sanofi will exchange its animal health business (Merial) with the consumer healthcare (CHC) business of Boehringer Ingelheim.
We can help with your specific research requirement for this market. Please share your specific interest to help us serve you better, Request Sample Pages:-
https://www.marketsandmarkets.com/requestsampleNew.asp?id=106215485

All Posts
×

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!

OKSubscriptions powered by Strikingly